COVID-19, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. China has achieved rapid containment of this highly infectious disease following the principles of early detection, early quarantine and early treatment with integrated traditional Chinese and Western medicine. The inclusion of traditional Chinese medicine (TCM) in the Chinese protocol is based on its successful historic experience in fighting against pestilence. Current findings have shown that the Chinese medicine can reduce the incidence of severe or critical events, improve clinical recovery and help alleviate symptoms such as cough or fever. To date there are over 133 ongoing registered clinical studies on TCM/integrated traditional Chinese and Western medicine. The three Chinese patent medicines (Lianhua Qingwen Keli/Jiaonang (Forsythiae and Honeysuckle Flower Pestilence-Clearing Granules/Capsules), Jinhua Qinggan Keli (Honeysuckle Flower Cold-Relieving Granules) and Xuebijing (Stasis-Resolving & Toxin-Removing) Injection were officially approved by the National Medical Products Administration to list COVID-19 as an additional indication. The pharmacological studies have suggested that Chinese medicine is effective for COVID-19 probably through its host-directed regulation and certain antiviral effects…
admin
Combating COVID-19 with integrated traditional Chinese and Western medicine in China
COVID-19, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. China has achieved rapid containment of this highly infectious disease following the principles of early detection, early quarantine and early treatment with integrated traditional Chinese and Western medicine. The inclusion of traditional Chinese medicine (TCM) in the Chinese protocol is based on its successful historic experience in fighting against pestilence. Current findings have shown that the Chinese medicine can reduce the incidence of severe or critical events, improve clinical recovery and help alleviate symptoms such as cough or fever. To date there are over 133 ongoing registered clinical studies on TCM/integrated traditional Chinese and Western medicine. The three Chinese patent medicines (Lianhua Qingwen Keli/Jiaonang (Forsythiae and Honeysuckle Flower Pestilence-Clearing Granules/Capsules), Jinhua Qinggan Keli (Honeysuckle Flower Cold-Relieving Granules) and Xuebijing (Stasis-Resolving & Toxin-Removing) Injection were officially approved by the National Medical Products Administration to list COVID-19 as an additional indication. The pharmacological studies have suggested that Chinese medicine is effective for COVID-19 probably through its host-directed regulation and certain antiviral effects…
Waning COVID-19 Antibodies Expected, No Cause for Alarm
Sorry, this entry is only available in 中文.類型: 連結 作者: Ricki Lewis 出處: Medscape 連結:...
《流行性感冒诊疗方案(2020年版)》印发,进一步完善轻症流感中医辨证治疗
Sorry, this entry is only available in 中文.類型: 連結 出處: 中国中医 連結: https://mp.weixin.qq.com/s/Bw41HinGjyMyUPldjayAng
《流行性感冒诊疗方案(2020年版)》印发,进一步完善轻症流感中医辨证治疗
Sorry, this entry is only available in 中文.類型: 連結 出處: 中国中医 連結: https://mp.weixin.qq.com/s/Bw41HinGjyMyUPldjayAng
《流行性感冒诊疗方案(2020年版)》印发,进一步完善轻症流感中医辨证治疗
Sorry, this entry is only available in 中文.類型: 連結 出處: 中国中医 連結: https://mp.weixin.qq.com/s/Bw41HinGjyMyUPldjayAng
《流行性感冒诊疗方案(2020年版)》印发,进一步完善轻症流感中医辨证治疗
Sorry, this entry is only available in 中文.類型: 連結 出處: 中国中医 連結: https://mp.weixin.qq.com/s/Bw41HinGjyMyUPldjayAng
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
Sorry, this entry is only available in 中文.類型: 連結 作者: J Zuo et al. 出處: bioRxiv 連結:...
New Return-to-Play Recommendations for Athletes With COVID-19
Sorry, this entry is only available in 中文.類型: 連結 作者: Fran Lowry 出處: Medscape 連結:...
How the Coronavirus Hacks the Immune System
Sorry, this entry is only available in 中文.類型: 連結 作者: James Somers 出處: New Yorker 連結:...